AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Urigrip 0.4mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Druto Laboratories

Salt Composition

Tamsulosin (0.4mg)

Overview Urigrip 0.4mg Tablet ER

Tamsulosin 0.4mg Extended-Release tablets are employed to manage benign prostatic hyperplasia (BPH). This alpha-blocker alleviates urinary symptoms such as hesitancy, but doesn't shrink the prostate gland. Dosage and duration should strictly adhere to your physician's instructions. This medication can be ingested with or without food, but consistently at the same time each day. Swallow the tablet whole; do not crush or chew. Discontinuing treatment prematurely without medical consultation may exacerbate symptoms. Complete the prescribed course for optimal results. Common side effects may include lightheadedness, back discomfort, chest pain, ejaculatory dysfunction, and retrograde ejaculation. Persistent or bothersome side effects warrant immediate medical attention. Lifestyle adjustments can aid symptom control. Urinate promptly upon feeling the urge, but avoid straining. Limit evening and pre-sleep/pre-外出 consumption of caffeinated or alcoholic beverages. Always disclose all current medications to your doctor before commencing treatment. If cataract or glaucoma surgery is planned, inform your ophthalmologist about your Tamsulosin use. Patients with hepatic impairment require careful monitoring and regular check-ups as directed by their physician.

Uses of Urigrip 0.4mg Tablet ER

Managing benign prostatic enlargement

Major Benefits of Urigrip 0.4mg Tablet ER:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Urigrip 0.4mg Extended-Release Tablets can be consumed with or without food, though consistent timing is recommended.

Common Side effects of Urigrip 0.4mg Tablet ER:

  • Chest pain
  • Inflammation of the nose
  • Dizziness
  • Ejaculation disorder
  • Headache
  • Abdominal pain
  • Back pain
  • Nausea
  • Infection

How to use Urigrip 0.4mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablet should be swallowed whole; do not crush, chew, or break it. Urigrip 0.4mg Extended-Release Tablets can be administered with or without food, although consistent timing is recommended.

How Urigrip 0.4mg Tablet ER works:

Urigrip 0.4mg Extended-Release tablets contain an alpha-adrenergic blocking agent. Its mechanism of action involves relaxing the bladder neck and prostatic smooth muscle, facilitating improved urinary flow. This promotes complete bladder emptying and lessens the frequency and urgency of urination associated with benign prostatic hyperplasia (BPH).

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Urigrip 0.4mg extended-release tablets and alcohol can lead to significant sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Data on the use of Urigrip 0.4mg extended-release tablets in pregnancy is lacking. Seek medical advice from your physician.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Urigrip 0.4mg Tablet ER while breastfeeding is likely unsafe. Available data in humans indicates potential transfer to breast milk, posing a risk to the infant. This medication is contraindicated in lactating women.

DrivingDrivingSAFE

Extended-release Urigrip 0.4mg tablets typically do not impair driving ability.

KidneyKidneySAFE IF PRESCRIBED

Urigrip 0.4mg Extended-Release tablets can be used safely by individuals with kidney disease without requiring a dosage change. Data on Urigrip 0.4mg Extended-Release tablets in patients exhibiting end-stage renal disease is scarce. Physician consultation is advised.

LiverLiverCAUTION

Patients with severe hepatic impairment should exercise caution when using Urigrip 0.4mg Extended-Release tablets. Dosage modification of Urigrip 0.4mg Extended-Release tablets may be necessary. Physician consultation is advised.

What if you forget to take Urigrip 0.4mg Tablet ER :

Should you forget a Urigrip 0.4mg Extended-Release Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Urigrip 0.4mg Tablet ER

LabelValue
Chemical Type Sulfonamide-based compound
Developing Habits No.
Type of Therapy Urological Care

FAQs on Urigrip 0.4mg Tablet ER

Take this capsule about 30 minutes after your first meal each day—either breakfast or dinner, as some doctors recommend nighttime use. Always swallow it whole with water; do not crush or chew.
Urigrip 0.4mg Extended-Release Tablets do not raise blood sugar. Report any blood sugar level changes to your doctor, as this may indicate another health issue requiring medical attention.
Urigrip 0.4mg ER tablets typically do not cause weight gain, even with prolonged use. However, consult your doctor if you experience weight gain while taking this medication.
You may notice improved urine flow 4 to 8 hours after taking a Urigrip 0.4mg Extended-Release tablet, but complete symptom relief may take 2 to 4 weeks.
Urigrip 0.4mg Extended-Release tablets may be safely taken with vitamin D; no adverse interactions are known.
Urigrip 0.4mg Extended-Release Tablets facilitate kidney stone passage through the urine by relaxing urinary tract muscles. This also reduces the need for pain medication.
Urigrip 0.4mg Extended-Release tablets cause blood vessel dilation, pooling blood in the extremities. This reduces blood flow to the brain, leading to postural hypotension. Consequently, patients may experience dizziness, lightheadedness, fainting, vertigo, or a spinning sensation.
Urigrip 0.4mg Extended-Release tablets may induce floppy iris syndrome, characterized by weakened iris muscles causing unexpected pupil constriction during cataract surgery. This constriction can impede the surgeon's view, potentially compromising surgical results.
Urigrip 0.4mg Extended-Release tablets relax blood vessel muscles, potentially leading to nasal congestion.
Urigrip 0.4mg Tablet ER isn't an anticholinergic; it eases prostate and bladder neck muscle contractions, thereby improving urine flow in men with benign prostatic hyperplasia. Concurrent use with anticholinergics can exacerbate symptoms.
Urigrip 0.4mg Tablet ER doesn't cause frequent urination; instead, it improves urine flow and reduces the urge to urinate often, a common symptom of benign prostatic hyperplasia (BPH). BPH also causes weak urinary stream and incomplete bladder emptying. Urigrip 0.4mg Tablet ER treats these urinary symptoms associated with BPH.
While Urigrip 0.4mg Tablet ER typically doesn't produce side effects in patients with benign prostatic hyperplasia, prolonged use might increase the risk of infections (including rhinitis and pharyngitis), pain, and cardiovascular events such as fainting, dizziness, lightheadedness, and hypotension. Prolonged use may also lead to ejaculatory dysfunction.
Managing your symptoms involves simple lifestyle adjustments. Address the urge to urinate promptly, but avoid straining. Restrict fluids, particularly alcohol and caffeine, several hours before sleep or outings. Consult your doctor before taking any additional medication, as some may worsen urinary urgency.
Urigrip 0.4mg Extended-Release tablets may be used concurrently with ibuprofen or paracetamol without known adverse interactions.
Urigrip 0.4mg Tablet ER
153
MRP 177
13% off